Category: Research
Relapse-free survival with adjuvant dabrafenib/trametinib therapy after relapse on a prior adjuvant CPI in BRAF V600-mutated stage III/IV melanoma
Background: In BRAF-mutated high-risk melanoma, targeted therapy (BRAF/MEK inhibitors) and checkpoint inhibitor (CPI) immunotherapy have durable benefits as first-line (1L) adjuvant therapy. Based on …
Impact of personalized response-directed surgery and adjuvant therapy on survival after neoadjuvant immunotherapy in stage III melanoma: Comparison of 3-year data from PRADO and OpACIN-neo
Background: Pathologic response following neoadjuvant immune checkpoint blockade (ICB) in stage III melanoma serves as a surrogate marker for long-term outcomes. This may support more personalized, re…
E-cigarettes may contribute to the development of oral squamous cell carcinoma
Electronic cigarettes are widely used by young adults, yet their impact on oral health, specifically in the context of oral squamous cell carcinoma (OSCC), is poorly understood. This study aimed to ev…
Read more about 'E-cigarettes may contribute to the development of oral squamous cell carcinoma'...
Molecular insights into the role of electronic cigarettes in oral carcinogenesis
Electronic cigarette (EC) usage or vaping has seen a significant rise in recent years across various parts of the world. They have been publicized as a safe alternative to smoking; however, this is no…